When.com Web Search

  1. Ads

    related to: rituximab treatment for pemphigus

Search results

  1. Results From The WOW.Com Content Network
  2. Pemphigus erythematosus - Wikipedia

    en.wikipedia.org/wiki/Pemphigus_erythematosus

    Rituximab (Anti-CD20 antibody) has been used to treat pemphigus erythematosus. Immunosuppressant medication is the most common treatment for pemphigus erythematosus. [ 1 ] Corticosteroids such as oral prednisone pills are an established long-term therapy for pemphigus.

  3. Pemphigus vulgaris - Wikipedia

    en.wikipedia.org/wiki/Pemphigus_vulgaris

    Pemphigus vulgaris is a rare chronic blistering skin disease and the most common form of pemphigus.Pemphigus was derived from the Greek word pemphix, meaning blister. [1] It is classified as a type II hypersensitivity reaction in which antibodies are formed against desmosomes, components of the skin that function to keep certain layers of skin bound to each other.

  4. Rituximab - Wikipedia

    en.wikipedia.org/wiki/Rituximab

    Rituximab, sold under the brand name Rituxan among others, is a monoclonal antibody medication used to treat certain autoimmune diseases and types of cancer. [18] It is used for non-Hodgkin lymphoma, chronic lymphocytic leukemia (in children and adults, but not recommended in elderly patients), rheumatoid arthritis, granulomatosis with polyangiitis, idiopathic thrombocytopenic purpura ...

  5. Roche Reports Positive Data on Rituxan for Pemphigus Vulgaris

    www.aol.com/news/roche-reports-positive-data...

    Roche (RHHBY) announces positive data on rheumatic diseases drug, Rituxan, for pemphigus vulgaris.

  6. Pemphigus - Wikipedia

    en.wikipedia.org/wiki/Pemphigus

    [17] [18] Currently rituximab is considered a first-line treatment for some pemphigus patients according to Delphi consensus recommendations [19] All of these drugs may cause severe side effects, so patients should be closely monitored by doctors. Once the outbreaks are under control, dosage is often reduced, to lessen side effects.

  7. AJ Kanwar - Wikipedia

    en.wikipedia.org/wiki/AJ_Kanwar

    He has more than 592 publications to his credit, in national and international Textbooks and Journals. In 2011, he was credited as first in India to report efficacy and safety of Rituximab for treatment of Pemphigus. [11] He is co-author of Textbook of Surgical Management of Vitiligo published by Blackwell [12] [13]

  1. Ad

    related to: rituximab treatment for pemphigus